US Markets

Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies

Credit: REUTERS/CHARLES PLATIAU

Translate Bio Inc said on Tuesday that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA induced immune response in early-stage non-human primate studies.

Aug 25 (Reuters) - Translate Bio Inc TBIO.O said on Tuesday that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA SASY.PA induced immune response in early-stage non-human primate studies.

In a regulatory filing, the company cited Sanofi's presentation slides showing that the vaccine candidate induced neutralizing antibodies and T-cell responses in animal studies.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)

((manojna.kalyani@thomsonreuters.com; +91 8061822700;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More